Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123397912 | 12339791 | 2 | F | 20151028 | 20160705 | 20160506 | 20160708 | EXP | DE-AMGEN-DEUSP2016055331 | AMGEN | 0.00 | M | Y | 0.00000 | 20160708 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123397912 | 12339791 | 1 | PS | pegfilgrastim | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, 1 IN 14 D | U | 125031 | 6 | MG | UNKNOWN FORMULATION | QOW | |||||
| 123397912 | 12339791 | 2 | SS | pegfilgrastim | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, 1 IN 1 D | U | 125031 | 6 | MG | UNKNOWN FORMULATION | QD | |||||
| 123397912 | 12339791 | 3 | SS | pegfilgrastim | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, 1 IN 1 D | U | 125031 | 6 | MG | UNKNOWN FORMULATION | QD | |||||
| 123397912 | 12339791 | 4 | SS | pegfilgrastim | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, 1 IN 1 D | U | 125031 | 6 | MG | UNKNOWN FORMULATION | QD | |||||
| 123397912 | 12339791 | 5 | SS | RITUXIMAB | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 375 MG/M2, 1 IN 14 D | 0 | 375 | MG/M**2 | INFUSION | QOW | ||||||
| 123397912 | 12339791 | 6 | SS | RITUXIMAB | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 640 MG, 1 IN 1 D | 0 | 640 | MG | INFUSION | QD | ||||||
| 123397912 | 12339791 | 7 | SS | RITUXIMAB | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 660 MG, 1 IN 1 D | 0 | 660 | MG | INFUSION | QD | ||||||
| 123397912 | 12339791 | 8 | SS | RITUXIMAB | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 650 MG, 1 IN 1 D | 0 | 650 | MG | INFUSION | QD | ||||||
| 123397912 | 12339791 | 9 | SS | RITUXIMAB | RITUXIMAB | 1 | Intravenous (not otherwise specified) | UNK, 1 IN 14 D | 0 | INFUSION | QOW | ||||||||
| 123397912 | 12339791 | 10 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 750 MG/M2, 1 IN 14 D | 0 | 750 | MG/M**2 | QOW | |||||||
| 123397912 | 12339791 | 11 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 960 MG, 1 IN 1 D | 0 | 960 | MG | QD | |||||||
| 123397912 | 12339791 | 12 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 1320 MG, 1 IN 1 D | 0 | 1320 | MG | QD | |||||||
| 123397912 | 12339791 | 13 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 980 MG, 1 IN 1 D | 0 | 980 | MG | QD | |||||||
| 123397912 | 12339791 | 14 | SS | DOXORUBICINE | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | 50 MG/M2, 1 IN 14 D | 0 | 50 | MG/M**2 | QOW | |||||||
| 123397912 | 12339791 | 15 | SS | DOXORUBICINE | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | 64 MG, 1 IN 1 D | 0 | 64 | MG | QD | |||||||
| 123397912 | 12339791 | 16 | SS | DOXORUBICINE | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | 88 MG, 1 IN 1 D | 0 | 88 | MG | QD | |||||||
| 123397912 | 12339791 | 17 | SS | DOXORUBICINE | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | 64 MG, 1 IN 1 D | 0 | 64 | MG | QD | |||||||
| 123397912 | 12339791 | 18 | SS | VINCRISTINE | VINCRISTINE | 1 | Intravenous (not otherwise specified) | 2 MG/M2, 1 IN 14 D | 0 | 2 | MG/M**2 | QOW | |||||||
| 123397912 | 12339791 | 19 | SS | VINCRISTINE | VINCRISTINE | 1 | Intravenous (not otherwise specified) | 3.4 MG, 1 IN 1 D | 0 | 3.4 | MG | QD | |||||||
| 123397912 | 12339791 | 20 | SS | VINCRISTINE | VINCRISTINE | 1 | Intravenous (not otherwise specified) | 3.46 MG, 1 IN 1 D | 0 | 3.46 | MG | QD | |||||||
| 123397912 | 12339791 | 21 | SS | VINCRISTINE | VINCRISTINE | 1 | Intravenous (not otherwise specified) | 3.46 MG, 1 IN 1 D | 0 | 3.46 | MG | QD | |||||||
| 123397912 | 12339791 | 22 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 100 MG, 1 IN 14 D | 1300 | MG | 0 | 100 | MG | QOW | |||||
| 123397912 | 12339791 | 23 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 100 MG, 1 IN 1 D | 1300 | MG | 0 | 100 | MG | QD | |||||
| 123397912 | 12339791 | 24 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 100 MG, 1 IN 1 D | 1300 | MG | 0 | 100 | MG | QD | |||||
| 123397912 | 12339791 | 25 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 100 MG, 1 IN 1 D | 1300 | MG | 0 | 100 | MG | QD | |||||
| 123397912 | 12339791 | 26 | C | ACICLOVIR | ACYCLOVIR | 1 | Oral | 1600 (400 MG, 4 IN 1 D) | 0 | 400 | MG | QID | |||||||
| 123397912 | 12339791 | 27 | C | SULFAMETHOXAZOLE AND TRIMETHOPRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 960 MG, 2 IN 1 WK | 0 | 960 | MG | BIW | |||||||
| 123397912 | 12339791 | 28 | C | AMPHOTERICIN B. | AMPHOTERICIN B | 1 | Oral | 400 MG (100 MG, 4 IN 1 D) | 0 | 100 | MG | QID | |||||||
| 123397912 | 12339791 | 29 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 300 MG, 1 IN 1 D | 0 | 300 | MG | QD | |||||||
| 123397912 | 12339791 | 30 | C | ASPIRIN. | ASPIRIN | 1 | 100 MG, 1 IN 1 D | 0 | 100 | MG | QD | ||||||||
| 123397912 | 12339791 | 31 | C | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | 4 MG, 1 IN 1 D | 0 | 4 | MG | QD | ||||||||
| 123397912 | 12339791 | 32 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 25 MG, UNK | 0 | 25 | MG | |||||||||
| 123397912 | 12339791 | 33 | C | PANTOPRAZOL | PANTOPRAZOLE SODIUM | 1 | 40 MG (20 MG, 2 IN 1 D) | 0 | 20 | MG | BID | ||||||||
| 123397912 | 12339791 | 34 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 20 MG, 1 IN 1 D | 0 | 20 | MG | QD | ||||||||
| 123397912 | 12339791 | 35 | C | CALCIUM FOLINATE | LEUCOVORIN CALCIUM | 1 | UNK UNK, DAILY DOSE 0-1-0-0 | 0 | QD | ||||||||||
| 123397912 | 12339791 | 36 | C | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | FOR 3 DAYS (500 MG, 2 IN 1 D) | 0 | 500 | MG | BID | |||||||
| 123397912 | 12339791 | 37 | C | MOXONIDIN | MOXONIDINE | 1 | 0.3 MG, 1 IN 1 D | 0 | .3 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123397912 | 12339791 | 1 | B-cell lymphoma |
| 123397912 | 12339791 | 5 | B-cell lymphoma |
| 123397912 | 12339791 | 10 | B-cell lymphoma |
| 123397912 | 12339791 | 14 | B-cell lymphoma |
| 123397912 | 12339791 | 18 | B-cell lymphoma |
| 123397912 | 12339791 | 22 | B-cell lymphoma |
| 123397912 | 12339791 | 26 | Prophylaxis |
| 123397912 | 12339791 | 27 | Prophylaxis |
| 123397912 | 12339791 | 28 | Prophylaxis |
| 123397912 | 12339791 | 29 | Prophylaxis |
| 123397912 | 12339791 | 36 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123397912 | 12339791 | DS |
| 123397912 | 12339791 | HO |
| 123397912 | 12339791 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123397912 | 12339791 | Circulatory collapse | |
| 123397912 | 12339791 | Fatigue | |
| 123397912 | 12339791 | Febrile neutropenia | |
| 123397912 | 12339791 | Pneumonia | |
| 123397912 | 12339791 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123397912 | 12339791 | 1 | 20151023 | 0 | ||
| 123397912 | 12339791 | 2 | 20151130 | 0 | ||
| 123397912 | 12339791 | 3 | 20151108 | 20151108 | 0 | |
| 123397912 | 12339791 | 4 | 20151219 | 20151219 | 0 | |
| 123397912 | 12339791 | 5 | 20151020 | 20151020 | 0 | |
| 123397912 | 12339791 | 6 | 20151125 | 0 | ||
| 123397912 | 12339791 | 7 | 20151104 | 20151104 | 0 | |
| 123397912 | 12339791 | 8 | 20151216 | 20151216 | 0 | |
| 123397912 | 12339791 | 9 | 20160121 | 20160121 | 0 | |
| 123397912 | 12339791 | 10 | 20151021 | 20151021 | 0 | |
| 123397912 | 12339791 | 11 | 20151126 | 0 | ||
| 123397912 | 12339791 | 12 | 20151105 | 20151105 | 0 | |
| 123397912 | 12339791 | 13 | 20151217 | 20151217 | 0 | |
| 123397912 | 12339791 | 14 | 20151021 | 20151021 | 0 | |
| 123397912 | 12339791 | 15 | 20151126 | 0 | ||
| 123397912 | 12339791 | 16 | 20151105 | 20151105 | 0 | |
| 123397912 | 12339791 | 17 | 20151217 | 20151217 | 0 | |
| 123397912 | 12339791 | 18 | 20151021 | 20151021 | 0 | |
| 123397912 | 12339791 | 19 | 20151126 | 0 | ||
| 123397912 | 12339791 | 20 | 20151105 | 0 | ||
| 123397912 | 12339791 | 21 | 20151217 | 20151217 | 0 | |
| 123397912 | 12339791 | 22 | 20151021 | 20151025 | 0 | |
| 123397912 | 12339791 | 23 | 20151126 | 20151130 | 0 | |
| 123397912 | 12339791 | 24 | 20151104 | 20151109 | 0 | |
| 123397912 | 12339791 | 25 | 20151217 | 20151217 | 0 | |
| 123397912 | 12339791 | 26 | 20151007 | 0 | ||
| 123397912 | 12339791 | 27 | 20151005 | 0 | ||
| 123397912 | 12339791 | 28 | 20151005 | 0 | ||
| 123397912 | 12339791 | 29 | 20151005 | 0 | ||
| 123397912 | 12339791 | 36 | 20151110 | 20151112 | 0 |